Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propene SCHEMBL560443 | 0.88 | LMNA (0.71) | LMNATHRB | |
| Acrolein SCHEMBL157907 | 0.87 | LMNA (0.60) | LMNATHRB | |
| SCHEMBL5960679 | 0.86 | LMNA (0.67) | LMNATHRB | |
| Vinyl Chloride SCHEMBL4142982 | 0.86 | LMNA (0.67) | LMNATHRB | |
| Acrolein SCHEMBL3930769 | 0.85 | LMNA (0.57) | LMNATHRB | |
| Ethylene SCHEMBL555416 | 0.84 | LMNA (0.86) | LMNATHRB | |
| Ethylene SCHEMBL3362390 | 0.84 | LMNA (0.86) | LMNATHRB | |
| SCHEMBL9459 | 0.84 | — | — | |
| SCHEMBL2094168 | 0.84 | LMNA (1.00) | LMNATHRB | |
| Vinyl Ether SCHEMBL8399501 | 0.83 | LMNA (0.63) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130190409-A1 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2013-07-25 | — | — | US | claimed |
| US-8420121-B2 | Drug delivery vehicles, methods of manufacture, and methods of use thereof | UNIVERSITY OF MASSACHUSETTS (US) | 2013-04-16 | — | — | US | claimed |
| US-20110200675-A1 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2011-08-18 | — | — | US | claimed |
| US-20210252156-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | HERON THERAPEUTICS INC (US) | 2021-08-19 | — | — | US | disclosed |
| EP-3834817-A1 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | Heron Therapeutics, Inc. (US) | 2021-06-16 | — | — | EP | disclosed |
| US-20200405866-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | HERON THERAPEUTICS, INC. | 2020-12-31 | — | — | US | disclosed |
| EP-3424492-B1 | SEMI-SOLID DELIVERY VECHICLE AND PHARMACEUTICAL COMPOSITIONS | HERON THERAPEUTICS INC (US) | 2020-05-27 | — | — | EP | disclosed |
| US-10357570-B2 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | HERON THERAPEUTICS, INC. (US) | 2019-07-23 | — | — | US | disclosed |
| EP-3424492-A1 | SEMI-SOLID DELIVERY VECHICLE AND PHARMACEUTICAL COMPOSITIONS | Heron Therapeutics, Inc. (US) | 2019-01-09 | — | — | EP | disclosed |
| US-20180339052-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | HERCULES CAPITAL, INC., AS AGENT | 2018-11-29 | — | — | US | disclosed |
| EP-2902012-B1 | Semi-solid delivery vehicle and pharmaceutical compositions | HERON THERAPEUTICS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| US-20020037300-A1 | Semi-solid delivery vehicle and pharmaceutical compositions | HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.) | 2002-03-28 | — | — | US | disclosed |
| WO-2001085139-A2 | SEMI-SOLID DELIVERY VEHICLE AND PHARMACEUTICAL COMPOSITIONS | ADVANCED POLYMER SYSTEMS, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| WO-1991011466-A1 | CROSS-LINKABLE VINYL ETHER POLYACETAL OLIGOMERS | ISP INVESTMENTS INC. (US) | 1991-08-08 | — | — | WO | disclosed |
| US-5036112-A | Cationic radiation curable containing photoimitator; coatings | GAF CHEMICALS CORPORATION (US) | 1991-07-30 | — | — | US | disclosed |
| EP-0051667-B1 | POLYMERS OF POLYKETENE ACETALS AND POLYOLS | SRI INTERNATIONAL (US) | 1986-03-05 | — | — | EP | disclosed |
| US-4230813-A | CROSSLINKED STYRENE TERPOLYMER ADDITIVE | HOOKER CHEMICALS & PLASTICS CORP. (US) | 1980-10-28 | — | — | US | disclosed |
| US-4125702-A | Additive for low profile polymerizable unsaturated polyester molding composition | HOOKER CHEMICALS & PLASTICS CORP. (US) | 1978-11-14 | — | — | US | disclosed |
| US-4052370-A | POLYURETHANES | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4043988-A | Low profile polyester molding composition | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037300-A1 | Semi-solid delivery vehicle and pharmaceutical compositions | LIPA, CEL, SORD | LMNA 3823/4885THRB 4373/4885 |
| US-20110200675-A1 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF | OGFR, OPRL1, OPRK1 | LMNA 4426/4885THRB 2073/4885 |
| US-20200405866-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | LPXN, CRH, NTSR1 | LMNA 3974/4885THRB 3672/4885 |
| US-20210252156-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | LPXN, CRH, NTSR1 | LMNA 3974/4885THRB 3672/4885 |
| US-10357570-B2 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | LPXN, CRH, NTSR1 | LMNA 3974/4885THRB 3672/4885 |
| US-20180339052-A1 | METHODS OF TREATING NAUSEA UTILIZING SEMI-SOLID DELIVERY VEHICLE COMPOSITIONS COMPRISING GRANISETRON | LPXN, CRH, NTSR1 | LMNA 3974/4885THRB 3672/4885 |
| US-20130190409-A1 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF | OGFR, OPRL1, OPRK1 | LMNA 4426/4885THRB 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.